TScan Therapeutics Balance Sheet (2020-2026)

Reported Financials

TScan Therapeutics Quarterly Balance Sheet

Periods 25 quarters

Latest Jun 2026

TScan Therapeutics reported total assets of $171.45M and total liabilities of $102.43M for the quarter ended Jun 2026, down 42.6% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation		5.08M				10.22M				14.60M				18.70M				21.57M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	182.31M	161.41M	140.84M	125.60M	137.31M	120.03M	95.61M	208.84M	155.19M	133.36M	140.51M	242.16M	133.12M	178.69M	154.11M	169.39M	169.51M	152.41M	128.06M	100.20M
Receivables - NetNet Receivables								31.93M
Receivables								31.93M
Prepaid Assets	4.69M	4.25M	4.91M	3.76M	3.87M	4.10M	5.30M	1.45M	2.14M	2.19M	1.94M	1.85M	2.96M	2.61M	3.15M	3.08M	3.71M	4.80M	4.71M	4.25M
Current Assets	187.00M	165.65M	145.75M	129.36M	141.18M	124.13M	100.91M	242.22M	217.57M	194.24M	164.72M	299.53M	274.08M	292.72M	254.84M	221.13M	188.16M	157.21M	132.77M	104.40M
Non-Current Assets
Property, Plant & Equipment (Net)	11.29M	11.77M	10.69M	10.80M	10.33M	10.10M	9.02M	8.21M	8.60M	7.74M	7.20M	7.62M	7.46M	7.24M	8.35M	9.52M	9.30M	8.71M	8.12M	7.74M
Other Non-Current Assets	0.59M	5.03M	5.03M	5.04M	5.04M	5.04M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M	5.03M
Non-Current Assets	17.89M	22.45M	22.45M	23.05M	24.28M	74.96M	72.67M	74.70M	73.81M	77.91M	76.11M	75.34M	73.94M	78.40M	77.87M	77.43M	74.06M	71.58M	69.22M	67.05M
Assets	204.89M	188.11M	168.20M	152.41M	165.45M	199.09M	173.58M	316.92M	291.38M	272.15M	240.83M	374.87M	348.03M	371.12M	332.71M	298.56M	262.23M	228.79M	201.99M	171.45M
Liabilities
Current Liabilities
Accounts Payables	5.07M	1.76M	2.89M	3.10M	2.71M	2.91M	2.77M	3.39M	3.20M	2.37M	2.12M	3.11M	3.65M	4.28M	4.97M	4.54M	6.35M	1.24M	2.30M	3.12M
Payables	5.07M	1.76M	2.89M	3.10M	2.71M	2.91M	2.77M	3.39M	3.20M	2.37M	2.12M	3.11M	3.65M	4.28M	4.97M	4.54M	6.35M	1.24M	2.30M	3.12M
Accumulated Expenses	4.29M	6.52M	3.01M	4.16M	6.16M	6.84M	7.44M	8.30M	9.26M	10.72M	8.79M	10.81M	11.18M	15.41M	9.61M	12.80M	10.77M	7.67M	8.59M	7.83M
Other Accumulated Expenses	0.67M	1.01M	0.16M	0.70M	1.29M	0.43M	0.43M	0.43M	0.43M	0.42M	0.26M	0.25M	0.25M	0.08M	0.20M	0.19M	0.19M	0.20M	0.20M	0.19M
Short term Debt									1.11M	3.35M	6.80M	10.34M								11.71M
Current Deferred Revenue	11.97M	11.41M	10.87M	8.17M	5.93M	3.87M		19.21M	15.21M	10.14M	10.44M	10.70M	9.93M	11.70M	10.27M	7.70M	5.19M	2.62M	1.64M	0.59M
Total Current Liabilities	22.94M	21.34M	18.46M	17.17M	16.59M	17.30M	14.05M	35.12M	33.15M	29.82M	31.48M	38.57M	28.66M	35.96M	29.82M	31.32M	29.21M	18.70M	19.97M	30.96M
Non-Current Liabilities
Non-Current Debt					29.07M	29.29M	29.50M	29.72M	28.84M	26.70M	23.45M	20.11M	30.65M	32.07M	32.18M	32.30M	32.41M	32.53M	32.65M	21.07M
Non-Current Deffered Revenue	2.84M	1.50M						7.64M	7.76M	5.62M	4.76M	3.96M	3.68M	1.25M	0.50M
Preferred Stock Liabilities
Operating Leases	4.79M	4.39M	3.95M	3.50M	3.03M	53.01M	51.97M	53.81M	52.66M	59.14M	58.18M	57.01M	55.81M	60.74M	59.88M	58.12M	56.30M	54.44M	52.45M	50.40M
Other Non-Current Liabilities	0.24M	0.10M	0.10M	0.10M	0.10M	0.05M	0.04M	0.02M	0.01M				0.15M	0.14M	0.12M	0.11M	0.28M
Total Non-Current Liabilities	30.58M	27.23M	22.41M	20.67M	48.70M	99.61M	95.52M	126.29M	122.41M				118.79M	130.01M	122.38M	121.73M	117.93M
Total Liabilities	30.82M	27.33M	22.51M	20.76M	48.80M	99.66M	95.56M	126.32M	122.42M	121.28M	117.86M	119.65M	118.94M	130.15M	122.51M	121.85M	118.20M	105.67M	105.07M	102.43M
Shareholder's Equity
Total Debt					29.07M	29.29M	29.50M	29.72M	29.95M	30.05M	30.25M	30.45M	30.65M	32.07M	32.18M	32.30M	32.41M	32.53M	32.65M	32.78M
Common Equity	174.07M	160.78M	145.69M	131.65M	116.66M	99.43M	78.02M	190.61M	168.96M	150.87M	122.97M	255.22M	229.09M	240.97M	210.20M	176.71M	144.02M	123.12M	96.92M	69.02M
Liabilities and Shareholders Equity	204.89M	188.11M	168.20M	152.41M	165.45M	199.09M	173.58M	316.92M	291.38M	272.15M	240.83M	374.87M	348.03M	371.12M	332.71M	298.56M	262.23M	228.79M	201.99M	171.45M
Retained Earnings	-78.00M	-92.16M	-108.31M	-123.41M	-139.70M	-158.38M	-180.94M	-205.00M	-228.00M	-247.60M	-277.74M	-309.40M	-339.30M	-375.10M	-409.22M	-446.20M	-481.90M	-504.86M	-533.53M	-563.90M

TScan Therapeutics Balance Sheet API

Pull TScan Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TCRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "TCRX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=TCRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

TScan Therapeutics TCRX Balance Sheet (2020-2026)

TScan Therapeutics Quarterly Balance Sheet

TScan Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password